Atara Biotherapeutics
ATRA
ATRA
154 hedge funds and large institutions have $376M invested in Atara Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.06% less ownership
Funds ownership: 4.27% → 4.22% (-0.06%)
52% less capital invested
Capital invested by funds: $776M → $376M (-$400M)
67% less call options, than puts
Call options by funds: $114K | Put options by funds: $342K
Holders
154
Holding in Top 10
2
Calls
$114K
Puts
$342K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$7.76M | |
| 3 | +$7.09M | |
| 4 |
Goldman Sachs
New York
|
+$6.88M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.61M |
Top Sellers
| 1 | -$21.3M | |
| 2 | -$14.5M | |
| 3 | -$10.3M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$7.79M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$4.81M |